219 related articles for article (PubMed ID: 22829596)
41. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system.
LaPorte SL; Juo ZS; Vaclavikova J; Colf LA; Qi X; Heller NM; Keegan AD; Garcia KC
Cell; 2008 Jan; 132(2):259-72. PubMed ID: 18243101
[TBL] [Abstract][Full Text] [Related]
42. Characterization of the cytoplasmic domain of interleukin-13 receptor-alpha.
Orchansky PL; Kwan R; Lee F; Schrader JW
J Biol Chem; 1999 Jul; 274(30):20818-25. PubMed ID: 10409622
[TBL] [Abstract][Full Text] [Related]
43. Diminished responses to IL-13 by human monocytes differentiated in vitro: role of the IL-13Ralpha1 chain and STAT6.
Hart PH; Bonder CS; Balogh J; Dickensheets HL; Vazquez N; Davies KV; Finlay-Jones JJ; Donnelly RP
Eur J Immunol; 1999 Jul; 29(7):2087-97. PubMed ID: 10427971
[TBL] [Abstract][Full Text] [Related]
44. IFN-gamma suppresses STAT6 phosphorylation by inhibiting its recruitment to the IL-4 receptor.
Huang Z; Xin J; Coleman J; Huang H
J Immunol; 2005 Feb; 174(3):1332-7. PubMed ID: 15661890
[TBL] [Abstract][Full Text] [Related]
45. IL-2 induces conformational changes in its preassembled receptor core, which then migrates in lipid raft and binds to the cytoskeleton meshwork.
Pillet AH; Lavergne V; Pasquier V; Gesbert F; Thèze J; Rose T
J Mol Biol; 2010 Nov; 403(5):671-92. PubMed ID: 20816854
[TBL] [Abstract][Full Text] [Related]
46. Interleukin-4 and interleukin-13 signaling connections maps.
Kelly-Welch AE; Hanson EM; Boothby MR; Keegan AD
Science; 2003 Jun; 300(5625):1527-8. PubMed ID: 12791978
[TBL] [Abstract][Full Text] [Related]
47. IL-4/IL-13 signaling beyond JAK/STAT.
Jiang H; Harris MB; Rothman P
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1063-70. PubMed ID: 10856136
[TBL] [Abstract][Full Text] [Related]
48. IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells.
Rahaman SO; Sharma P; Harbor PC; Aman MJ; Vogelbaum MA; Haque SJ
Cancer Res; 2002 Feb; 62(4):1103-9. PubMed ID: 11861389
[TBL] [Abstract][Full Text] [Related]
49. Structure, binding, and antagonists in the IL-4/IL-13 receptor system.
Mueller TD; Zhang JL; Sebald W; Duschl A
Biochim Biophys Acta; 2002 Nov; 1592(3):237-50. PubMed ID: 12421669
[TBL] [Abstract][Full Text] [Related]
50. Involvement of the IL-2 receptor gamma-chain (gammac) in the control by IL-4 of human monocyte and macrophage proinflammatory mediator production.
Bonder CS; Dickensheets HL; Finlay-Jones JJ; Donnelly RP; Hart PH
J Immunol; 1998 Apr; 160(8):4048-56. PubMed ID: 9558115
[TBL] [Abstract][Full Text] [Related]
51. Induction of the IL-13 receptor alpha2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways.
David M; Ford D; Bertoglio J; Maizel AL; Pierre J
Oncogene; 2001 Oct; 20(46):6660-8. PubMed ID: 11709700
[TBL] [Abstract][Full Text] [Related]
52. IL-4 and IL-13 Promote Proliferation of Mammary Epithelial Cells through STAT6 and IRS-1.
Wu WJ; Wang SH; Wu CC; Su YA; Chiang CY; Lai CH; Wang TH; Cheng TL; Kuo JY; Hsu TC; Lin TH; Lee YJ
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769439
[TBL] [Abstract][Full Text] [Related]
53. The two subunits of the interleukin-4 receptor mediate independent and distinct patterns of ligand endocytosis.
Friedrich K; Kammer W; Erhardt I; Brändlein S; Arnold S; Sebald W
Eur J Biochem; 1999 Oct; 265(1):457-65. PubMed ID: 10491204
[TBL] [Abstract][Full Text] [Related]
54. Interleukin-2 (IL-2)-mediated induction of the IL-2 receptor alpha chain gene. Critical role of two functionally redundant tyrosine residues in the IL-2 receptor beta chain cytoplasmic domain and suggestion that these residues mediate more than Stat5 activation.
Ascherman DP; Migone TS; Friedmann MC; Leonard WJ
J Biol Chem; 1997 Mar; 272(13):8704-9. PubMed ID: 9079703
[TBL] [Abstract][Full Text] [Related]
55. Comparison of IL-13- and IL-4-induced signaling in EBV-immortalized human B cells.
Murata T; Puri RK
Cell Immunol; 1997 Jan; 175(1):33-40. PubMed ID: 9015186
[TBL] [Abstract][Full Text] [Related]
56. A toll-like receptor-based two-hybrid assay for detecting protein--protein interactions on live eukaryotic cells.
Wang L; Zhang H; Zhong F; Lu J
J Immunol Methods; 2004 Sep; 292(1-2):175-86. PubMed ID: 15350522
[TBL] [Abstract][Full Text] [Related]
57. SIRPα sequesters SHP-2 to promote IL-4 and IL-13 signaling and the alternative activation of macrophages.
Shi L; Kidder K; Bian Z; Chiang SKT; Ouellette C; Liu Y
Sci Signal; 2021 Sep; 14(702):eabb3966. PubMed ID: 34582250
[TBL] [Abstract][Full Text] [Related]
58. Acute lymphoblastic leukemia-associated JAK1 mutants activate the Janus kinase/STAT pathway via interleukin-9 receptor alpha homodimers.
Hornakova T; Staerk J; Royer Y; Flex E; Tartaglia M; Constantinescu SN; Knoops L; Renauld JC
J Biol Chem; 2009 Mar; 284(11):6773-81. PubMed ID: 19139102
[TBL] [Abstract][Full Text] [Related]
59. New programming of IL-4 receptor signal transduction in activated T cells: Stat6 induction and Th2 differentiation mediated by IL-4Ralpha lacking cytoplasmic tyrosines.
Mora AL; Stephenson LM; Enerson B; Youn J; Keegan AD; Boothby M
J Immunol; 2003 Aug; 171(4):1891-900. PubMed ID: 12902491
[TBL] [Abstract][Full Text] [Related]
60. Modulation of interleukin (IL)-13 binding and signaling by the gammac chain of the IL-2 receptor.
Obiri NI; Murata T; Debinski W; Puri RK
J Biol Chem; 1997 Aug; 272(32):20251-8. PubMed ID: 9242704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
